魯北化工(600727.SH):2022年度擬向銀行申請不超20億元授信額度
格隆匯3月24日丨魯北化工(600727.SH)公佈,根據公司2022年年度生產經營及投資計劃的資金需求,為保證公司生產經營等各項工作順利進行,降低融資成本,提高資金營運能力,同意公司及子公司2022年擬向銀行申請敞口授信(不包含保證金、存單、結構性存款,銀承質押等擔保的低風險授信)額度20億元人民幣,融資期限以實際簽署的合同為準。上述授信額度不等於公司實際融資金額,實際授信額度最終以銀行最後審批的授信額度為準,具體融資金額將視公司運營資金的實際需求來確定。在授信期限內,授信額度可循環使用。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.